A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Clinical trial NCT07277270 · RECRUITING
Trial details
- NCT number
- NCT07277270
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-03
- Primary completion
- 2026-07-13
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.